Sequential infusion of donor-derived dendritic cells with donor lymphocyte infusion for relapsed hematologic cancers after allogeneic hematopoietic stem cell transplantation

American Journal of Hematology

Volumn 89, Issue 12, 2014, Pages 1092-1096

  Ho, Vincent T ^a   Kim, Haesook T ^a   Kao, Grace ^b   Cutler, Corey ^a   Levine, James ^a   Rosenblatt, Jacalyn ^a   Joyce, Robin ^a   Antin, Joseph H ^a   Soiffer, Robert J ^a   Ritz, Jerome ^a   Avigan, David ^a   Alyea, Edwin P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; IL4 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADAPTIVE IMMUNITY; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOPSY; CANCER RECURRENCE; CANCER REGRESSION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DENDRITIC CELL; DISEASE COURSE; DONOR DENDRITIC CELL INFUSION; DONOR LYMPHOCYTE INFUSION; FEMALE; HEART ARREST; HEMATOLOGIC MALIGNANCY; HLA SYSTEM; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION CONTROL; LARGE CELL LYMPHOMA; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MIXED LYMPHOCYTE REACTION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PATIENT SAFETY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY FAILURE; T LYMPHOCYTE; AGED; ALLOTRANSPLANTATION; CELL CULTURE; CLINICAL TRIAL; CYTOLOGY; DONOR; DRUG EFFECTS; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE TRANSFUSION; PATHOLOGY; RECURRENT DISEASE; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INTERLEUKIN-4; LYMPHOCYTE TRANSFUSION; LYMPHOCYTES; MALE; MIDDLE AGED; RECURRENCE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922393832     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23825     Document Type: Article

References (13)

1. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041-2050.
2. Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [see comments]. J Clin Oncol 1997;15:433-444.
3. Bernhard H, Disis ML, Heimfeld S, et al. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 1995;55:1099-1104.
4. Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
5. Nestle Fo, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 1998;4:328-332.
6. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-58.
7. Thurnher M, Rieser C, Holtl L, et al. Dendritic cell-based immunotherapy of renal cell carcinoma. Urol Int 1998;61:67-71.
8. Lopez MN, Pereda C, Segal G, et al. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells. J Clin Oncol 2009;27:945-952.
9. Ash S, Stein J, Askenasy N, et al. Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation. Br J Cancer 2010;103:1597-1605.
10. Przepiorka D, Weisdorf D, Martin P, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Trasnplant 1995;15:825-828.
11. El-Jurdi N, Reljic T, Kumar A, et al. Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies. Immunotherapy 2013;5:457-466.
12. Ho VT, Vanneman M, Kim H, et al. Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 2009;106:15825-15830.
13. Vasir B, Borges V, Wu Z, et al. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation. Br J Haematol 2005;129:687-700.